12:00 AM
 | 
Aug 04, 2008
 |  BioCentury  |  Regulation

Safety in numbers

Safety in numbers

The size of premarket safety databases of biologics for RA have expanded dramatically since Enbrel was approved in 1998. When Enbrel was reviewed, a total of 733 RA patients had...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >